The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology.

Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-small ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Researchers found that adherence to the first and second annual screenings was 61% and 51%, respectively, with higher lung ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

John “Paddy” Hemingway, the last surviving Battle of Britain pilot, has died at 105. He played a crucial role in defending Britain from Luftwaffe raids in 1940. Hemingway's squadron downed 90 ...

President of the European Commission Ursula von der Leyen at the end of an E.U. Summit in Brussels on March 22, 2024. The Ukraine peace process initiated by the Trump Administration—which this ...

March 12, 2025 • The European Union on Wednesday announced retaliatory trade action with a series of duties on U.S. products, responding to the Trump administration rise in tariffs on all steel ...

They may also need to provide fingerprints at the borders of 29 European countries - replacing the current system of passport stamps. However, both EU border control schemes have repeatedly been ...

A senior military source tells Al Jazeera a multinational force needs a ‘maximalist approach’ to deter Russia.